Medications

Maker of Wegovy limits supply of obesity drug in US

Danish drugmaker Novo Nordisk said Thursday it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough supply.

Overweight & Obesity

New guidance: Use drugs, surgery early for obesity in kids

Children struggling with obesity should be evaluated and treated early and aggressively, including with medications for kids as young as 12 and surgery for those as young as 13, according to new guidelines released Monday.

page 24 from 40